Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

Son, 2010, Contribution of gut bacteria to liver pathobiology, Gastroenterol Res Pract, 10.1155/2010/453563 Guarner, 2003, Gut flora in health and disease, Lancet, 361, 512, 10.1016/S0140-6736(03)12489-0 Abt, 2009, The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis, Curr Opin Gastroenterol, 25, 496, 10.1097/MOG.0b013e328331b6b4 Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 1635, 10.1126/science.1110591 O'Hara, 2006, The gut flora as a forgotten organ, EMBO Rep, 7, 688, 10.1038/sj.embor.7400731 Neish, 2009, Microbes in gastrointestinal health and disease, Gastroenterology, 136, 65, 10.1053/j.gastro.2008.10.080 Zhang, 2001, Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity, J Clin Invest, 107, 13, 10.1172/JCI11837 Clavel, 2007, Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation, Curr Issues Intest Microbiol, 8, 25 Shanahan, 2002, The host-microbe interface within the gut, Best Pract Res Clin Gastroenterol, 16, 915, 10.1053/bega.2002.0342 Xu, 2003, Honor thy symbionts, Proc Natl Acad Sci U S A, 100, 10452, 10.1073/pnas.1734063100 Wells, 2011, Epithelial crosstalk at the microbiota-mucosal interface, Proc Natl Acad Sci U S A, 108, 4607, 10.1073/pnas.1000092107 Cani, 2009, The role of the gut microbiota in energy metabolism and metabolic disease, Curr Pharm Des, 15, 1546, 10.2174/138161209788168164 Othman, 2008, Alterations in intestinal microbial flora and human disease, Curr Opin Gastroenterol, 24, 11, 10.1097/MOG.0b013e3282f2b0d7 Nagata, 2007, Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis, J Toxicol Sci, 32, 453, 10.2131/jts.32.453 Zeuzem, 2000, Gut-liver axis, Int J Colorectal Dis, 15, 59, 10.1007/s003840050236 Han, 2002, Intestinal endotoxemia as a pathogenetic mechanism in liver failure, World J Gastroenterol, 8, 961, 10.3748/wjg.v8.i6.961 Bilzer, 2006, Role of Kupffer cells in host defense and liver disease, Liver Int, 26, 1175, 10.1111/j.1478-3231.2006.01342.x Jirillo, 2002, The role of the liver in the response to LPS: experimental and clinical findings, J Endotoxin Res, 8, 319 Bedogni, 2010, Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children, Nutr Metab Cardiovasc Dis Succurro, 2011, One-hour post-load plasma glucose levels are associated with elevated liver enzymes, Nutr Metab Cardiovasc Dis, 21, 713, 10.1016/j.numecd.2011.02.002 Abete, 2011, Obesity and metabolic syndrome: potential benefit from specific nutritional components, Nutr Metab Cardiovasc Dis, 21, B1, 10.1016/j.numecd.2011.05.001 Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 Law, 2010, Nonalcoholic fatty liver disease, Clin Liver Dis, 14, 591, 10.1016/j.cld.2010.07.006 Tilg, 2010, Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis, Hepatology, 52, 1836, 10.1002/hep.24001 Vanni, 2009, The gut-liver axis in nonalcoholic fatty liver disease: another pathway to insulin resistance?, Hepatology, 49, 1790, 10.1002/hep.23036 Solga, 2003, Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics, J Hepatol, 38, 681, 10.1016/S0168-8278(03)00097-7 Diamant, 2011, Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?, Obes Rev, 12, 272, 10.1111/j.1467-789X.2010.00797.x Thuy, 2008, Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake, J Nutr, 138, 1452, 10.1093/jn/138.8.1452 Miele, 2009, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, Hepatology, 49, 1877, 10.1002/hep.22848 Pappo, 1991, Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat, J Surg Res, 51, 106, 10.1016/0022-4804(91)90078-Z Drenick, 1982, Hepatic steatosis after intestinal bypass-prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition, Gastroenterology, 82, 535, 10.1016/S0016-5085(82)80403-4 Abu-Shanab, 2010, The role of the gut microbiota in nonalcoholic fatty liver disease, Nat Rev Gastroenterol Hepatol, 7, 691, 10.1038/nrgastro.2010.172 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Bäckhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci U S A, 101, 15718, 10.1073/pnas.0407076101 Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a Spencer, 2011, Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency, Gastroenterology, 140, 976, 10.1053/j.gastro.2010.11.049 Szabo, 2005, Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4, Alcohol Clin Exp Res, 29, 140S, 10.1097/01.alc.0000189287.83544.33 Miura, 2010, Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease, Gastroenterol Res Pract, 2010, 362847, 10.1155/2010/362847 Rivera, 2007, Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis, J Hepatol, 47, 571, 10.1016/j.jhep.2007.04.019 Rivera, 2010, Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis, BMC Gastroenterol, 10, 52, 10.1186/1471-230X-10-52 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Minocha, 2009, Probiotics for preventive health, Nutr Clin Pract, 24, 227, 10.1177/0884533608331177 Nardone, 2004, Probiotics: a potential target for the prevention and treatment of steatohepatitis, J Clin Gastroenterol, 38, S121, 10.1097/01.mcg.0000128934.53920.1d Li, 2003, Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease, Hepatology, 37, 343, 10.1053/jhep.2003.50048 Ewaschuk, 2007, Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis, Hepatology, 46, 841, 10.1002/hep.21750 Ma, 2008, Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells, J Hepatol, 49, 821, 10.1016/j.jhep.2008.05.025 Velayudham, 2009, VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice, Hepatology, 49, 989, 10.1002/hep.22711 Nardone, 2010, Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury, Am J Physiol Gastrointest Liver Physiol, 299, G669, 10.1152/ajpgi.00188.2010 Aller, 2011, Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial, Eur Rev Med Pharmacol Sci, 15, 1090 Parnell, 2011, The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance, Liver Int